Establishment of a national network of validated and qualified laboratories for neutralizing anti-vaccinia antibodies titration.

A Proficiency Testing Study (PTS) was organized in France by the French Health Products Safety Agency (Afssaps) aiming at assessing the performance of laboratories in performing a neutralizing anti-vaccinia antibodies titration method by plaque reduction neutralization test (PRNT). The ultimate goal was to establish a national network of qualified and validated laboratories. Five laboratories were included in the PTS and four submitted their data. Three samples of human sera containing various immunoglobulin concentrations (a "high" serum: s-576, a "medium" serum: Ref-19584 and a "low" serum: s-483) were tested by PRNT as described in a procedure supplied by Afssaps and developed in each laboratory during preliminary assays. Data were sent to Afssaps which performed the statistical analysis. The overall performance of the four participating laboratories was satisfactory. This allowed the four participating laboratories to be validated and then to be qualified by the Ministry of Health. Finally a national network for anti-vaccinia immunoglobulins titration was established.
AuthorsBertrand Poirier, Isabelle Leparc-Goffart, Jean-Marc Crance, Hervé Fleury, Daniel Garin, Jean-Pierre Gut, Marie-Hélène Tissier, Florence Fuchs
JournalBiologicals : journal of the International Association of Biological Standardization (Biologicals) Vol. 33 Issue 4 Pg. 277-82 (Dec 2005) ISSN: 1045-1056 [Print] England
PMID16181788 (Publication Type: Comparative Study, Journal Article, Validation Studies)
Chemical References
  • Antibodies, Viral
  • Smallpox Vaccine
  • Antibodies, Viral (analysis, blood)
  • Evaluation Studies as Topic
  • France
  • Humans
  • Laboratories (standards)
  • Neutralization Tests (methods)
  • Reference Standards
  • Reproducibility of Results
  • Smallpox Vaccine (analysis)
  • Vaccinia virus (genetics, immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: